Latest Pharma Deals Draw Counsel from Am Law Firms
AstraZeneca has agreed to buy the rights to respiratory drugs owned by Almirall for $2.1 billion, with Covington & Burling and British firm CMS Cameron McKenna. Meanwhile, Kirkland & Ellis and Sidley Austin are leading the way on Pfizer's acquisition of Baxter International's vaccine portfolio.
This premium content is reserved for American Lawyer subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now